Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Adjuvant Chemotherapy 96%
3. Drug Therapy 83%
4. Fluorouracil 78%
5. Melphalan 59%
6. Methotrexate 56%
7. Anus Neoplasms 55%
8. Head and Neck Neoplasms 53%
9. Tamoxifen 50%
10. Squamous Cell Neoplasms 44%
11. Radiotherapy 43%
12. Recurrence 42%
13. Mitomycin 39%
14. Glioma 32%
15. Radiation 31%
16. Anal Canal Carcinoma 29%
17. Colorectal Neoplasms 28%
18. Upper Extremity Deep Vein Thrombosis 28%
19. Leucovorin 27%
20. Placebos 24%
21. Clinical Trials 23%
22. Anal Canal 23%
23. Neoplasms 22%
24. National Cancer Institute (U.S.) 22%
25. Morbidity 22%
26. Segmental Mastectomy 20%
27. Blood Cell Count 20%
28. Docetaxel 19%
29. gemcitabine 19%
30. Small Cell Lung Carcinoma 19%
31. CMFVP protocol 19%
32. Survival 19%
33. Verapamil 19%
34. Warfarin 18%
35. Therapeutics 18%
36. Endometrium 18%
37. Melanoma 18%
38. T-Lymphocytes 18%
39. Clinical Protocols 17%
40. Regulatory T-Lymphocytes 17%
41. Confidence Intervals 16%
42. Non-Hodgkin's Lymphoma 16%
43. Canada 16%
44. Antigens 15%
45. Cyclophosphamide 14%
46. Adenocarcinoma 13%
47. Breast 13%
48. Randomized Controlled Trials 13%
49. Squamous Cell Carcinoma of Head and Neck 11%
50. Vincristine 11%